This focused issue on “Nutrition, Gut Microbiome, and Liver Cancer” is edited by Dr. Yu-Jui Yvonne Wan, Professor and Vice Chair of Research, Department of Medical Pathology & Laboratory Medicine, University of California, Davis, USA.
Professor Wan is the Vice Chair of the Department of Pathology and Laboratory of Medicine at University of California, Davis. Her research focuses on how nutrients and xenobiotics through gut microbiota and their metabolites affecting health and disease process. She has extensive expertise in liver metabolism, detoxification, steatohepatitis, carcinogenesis, and regeneration.
Focused issue outline:
- State of the art progress on nutrition, gut microbiome and liver cancer
- Gut microbiota and diabetes
- The role of Gut microbiota in metabolic syndrome
- Molecular and cellular mechanisms of hepatocellular carcinoma
- The underlying mechanism of gut microbiota in human health
- Role of gut microbiota in personalized nutrition
- Bile acids and their receptors
- Current progress of gut microbiota management in liver cancer/inflammation
- Impact of gut microbiota in human nutrition
- Impact of vitamin D3 supplementation in the management of gut microbiota in patients with cystic fibrosis
- Novel insight of gut microbiota in liver disease
- Impact of gut microbiota dysbiosis on malnutrition